ArticleCureus2025
Introduction of Exercise Therapy Using Hybrid Assistive Limb (HAL®) Lumbar Type for Diabetes Patients: A Pilot Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundExercise therapy is essential for diabetes management, but adherence remains challenging for many patients. The hybrid assistive limb (HAL) lumbar type is a wearable robot that has shown effectiveness in various conditions, yet its application in diabetes patients has not been investigated.
objectiveTo evaluate the feasibility and safety of exercise therapy using the HAL lumbar type for patients with diabetes and to exploratorily investigate its effects on physical function and metabolic parameters.
methodsThis pilot, prospective, single-arm study included nine patients with diabetes (mean age: 69.00±13.23 years). Participants underwent an exercise program using the HAL lumbar type, consisting of eight sessions of 60 minutes each. The program included stretching, squatting, and walking exercises, performed 1-2 times per week, with the goal of completion within 4 to 8 weeks. The primary outcome was the Sit-To-Stand test (STS test). Secondary outcomes included changes in body weight, body mass index (BMI), and metabolic parameters.
resultsAll participants completed the intervention without adverse events. Significant improvements were observed in the STS test (15.86±3.87 to 10.43±2.27 seconds, p<0.005), body weight (72.68±15.73 to 70.71±15.15 kg, p<0.05), and lipid metabolism parameters including total cholesterol (200.11±32.85 to 182.67±21.45 mg/dL, p<0.05) and LDL cholesterol (114.00±28.51 to 101.56±24.52 mg/dL, p<0.005).
conclusionExercise therapy using the HAL lumbar type was safely implemented in diabetes patients and showed potential benefits in improving physical function and lipid metabolism. These findings suggest that HAL-assisted exercise therapy might be a promising new approach for diabetes management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.